Bupropion hydrochloride produces conditioned hyperactivity in rats
Abstract
Bupropion is marketed as an antidepressant, Wellbutrin and smoking cessation aid, Zyban. Although the therapeutic neurological mechanisms of bupropion have not been fully elucidated, bupropion shares some behavioral similarities with classic psychomotor stimulants. The present study sought to further investigate these psychomotor stimulant effects of bupropion by assessing whether repeated administration of bupropion in a distinct environment produced conditioned hyperactivity. Paired rats received 10 daily i.p. injections of bupropion (2.5-30 mg/kg) before placement in locomotor chambers for 30 min. Bupropion (10-30 mg/kg) produced acute locomotor hyperactivity compared to Unpaired controls. After repeated administration, there was no progressive increase or decrease in bupropion-induced activity. In a subsequent drug-free session conditioned hyperactivity was observed at 5-30 mg/kg doses. In a follow-up experiment, we examined whether responsiveness to novelty predicted the subsequent unconditioned and conditioned locomotor effect of bupropion. Reactivity to inescapable novelty, novel environment approach, and novel-object interaction were measured before locomotor conditioning with 30 mg/kg bupropion. We replicated the previous experiment, but scores on the novelty screens did not predict locomotor response to bupropion. This study extends the literature by demonstrating that environmental cues repeatedly paired with the stimulant effects of bupropion come to evoke elevated activity in the absence of drug (i.e., conditioned hyperactivity). This finding is consistent with the literature suggesting that bupropion shares many behavioral similarities with other psychomotor stimulants which also produce conditioned hyperactivity. However, a predictive relation between reactivity to forced novelty and the subsequent locomotor effect of bupropion may not be one of these similarities.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both bupropion and nicotine are psychomotor stimulants.
“Both drugs are psychomotor stimulants [225, 226]”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [226]
Cites
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,355 · see citing works
Piazza, P. V., & Le Moal, M. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002043 · Cited by 690 · see citing works
Bupropion: a review of its mechanism of antidepressant activity.
Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., & Richelson, E. (1995) · PubMed · Cited by 680 · see citing works
Psychobiology of novelty seeking and drug seeking behavior
Bardo, M. T., Donohew, R. L., & Harrington, N. G. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00203-0 · Cited by 667 · see citing works
Corticosterone levels determine individual vulnerability to amphetamine self-administration.
Piazza, P. V., Maccari, S., Deminière, J.-M., Moal, M. L., Mormède, P., & Simon, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2088 · Cited by 567 · see citing works
Bupropion is a nicotinic antagonist
Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509 · see citing works
Fryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283 · see citing works
Bupropion versus Methylphenidate in the Treatment of Attention-Deficit Hyperactivity Disorder
BARRICKMAN, L. L., PERRY, P. J., ALLEN, A. J., KUPERMAN, S., ARNDT, S. V., HERRMANN, K. J., & SCHUMACHER, E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199505000-00017 · Cited by 254 · see citing works
Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1445-7 · Cited by 223 · see citing works
Cooper, B. R., Hester, T. J., & Maxwell, R. A. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32266-4 · Cited by 213 · see citing works
Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone
Moldow, R. L., & Fischman, A. J. (1987) · Peptides · doi:10.1016/0196-9781(87)90065-9 · Cited by 212 · see citing works
Damaj, M. I., Carroll, F. I., Eaton, J. B., Navarro, H. A., Blough, B. E., Mirza, S., Lukas, R. J., & Martin, B. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001313 · Cited by 212 · see citing works
Klebaur, J. E., Bevins, R. A., Segar, T. M., & Bardo, M. T. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200107000-00005 · Cited by 140 · see citing works
Individual differences in amphetamine sensitization: Dose-dependent effects
Hooks, M. S., Jones, G. H., Neill, D. B., & Justice, J. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90083-r · Cited by 138 · see citing works
Studies of bupropion's mechanism of antidepressant activity.
Ferris, R. M., Cooper, B. R., & Maxwell, R. A. (1983) · PubMed · Cited by 127 · see citing works
Classical conditioning, decay and extinction of cocaine-induced hyperactivity and stereotypy
Barr, G. A., Sharpless, N. S., Cooper, S. D., Schiff, S. R., Paredes, W. M., & Bridger, W. H. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90817-2 · Cited by 118 · see citing works
Hooks, M. S., Jones, G. H., Liem, B., & Justice, J. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90413-a · Cited by 112 · see citing works
Deroche‐Gamonet, V., Piazza, P. V., Moal, M. L., & Simon, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)91451-w · Cited by 111 · see citing works
The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
Gold, L. H., Swerdlow, N. R., & Koob, G. F. (1988) · Behavioral Neuroscience · doi:10.1037//0735-7044.102.4.544 · Cited by 109 · see citing works
Nomikos, G. G., Damsma, G., Wenkstern, D., & Fibiger, H. C. (1992) · PubMed · Cited by 109 · see citing works
Bevins, R. A., Besheer, J., Palmatier, M. I., Jensen, H. C., Pickett, K. S., & Eurek, S. E. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00326-6 · Cited by 98 · see citing works
Effect of Amphetamine on Plasma Corticosterone in the Conscious Rat
Knych, E. T., & Eisenberg, R. M. (2008) · Neuroendocrinology · doi:10.1159/000122912 · Cited by 95 · see citing works
Psychomotor-stimulant sensitization
Wise, R. A., & Leeb, K. (1993) · Behavioural Pharmacology · doi:10.1097/00008877-199308000-00007 · Cited by 91 · see citing works
The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
Gold, L. H., Swerdlow, N. R., & Koob, G. F. (1988) · Behavioral Neuroscience · doi:10.1037/0735-7044.102.4.544 · Cited by 87 · see citing works
Gormezano, I. (2013) · Psychology Press eBooks · doi:10.4324/9780203772515 · Cited by 86 · see citing works
Besheer, J., Palmatier, M. I., Metschke, D. M., & Bevins, R. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1621-9 · Cited by 85 · see citing works
Miller, D. K., Sumithran, S. P., & Dwoskin, L. P. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.033852 · Cited by 84 · see citing works
Dellu-Hagedorn, F. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(96)00017-0 · Cited by 80 · see citing works
Behaviour in the novel environment predicts responsiveness to d-amphetamine in the rat
Exner, M., & Clark, D. (1993) · Behavioural Pharmacology · doi:10.1097/00008877-199302000-00005 · Cited by 80 · see citing works
Bevins, R. A., Besheer, J., & Pickett, K. S. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00451-2 · Cited by 78 · see citing works
Tella, S. R., Ladenheim, B., & Cadet, J. L. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36624-8 · Cited by 76 · see citing works
Stimulus properties of antidepressants in the rat
Jones, C. N., Howard, J. L., & McBennett, S. T. (1980) · Psychopharmacology · doi:10.1007/bf00431964 · Cited by 71 · see citing works
Duvauchelle, C. L., Ikegami, A., & Castañeda, E. (2000) · Behavioral Neuroscience · doi:10.1037//0735-7044.114.6.1156 · Cited by 70 · see citing works
Lamb, R. J., & Griffiths, R. R. (1990) · Psychopharmacology · doi:10.1007/bf02245920 · Cited by 70 · see citing works
Jodogne, C., Marinelli, M., Moal, M. L., & Piazza, P. V. (1994) · Brain Research · doi:10.1016/0006-8993(94)90973-3 · Cited by 63 · see citing works
Novelty Seeking and Reward: Implications for the Study of High-Risk Behaviors
Bevins, R. A. (2001) · Current Directions in Psychological Science · doi:10.1111/1467-8721.00146 · Cited by 63 · see citing works
Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats
Mazurski, E. J., & Beninger, R. J. (1991) · Psychopharmacology · doi:10.1007/bf02316871 · Cited by 62 · see citing works
Piacentini, M. F., Clinckers, R., MEEUSEN, R. R., Sarre, S., Ebinger, G., & Michotte, Y. M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01058.2002 · Cited by 61 · see citing works
Duvauchelle, C. L., Ikegami, A., & Castañeda, E. (2000) · Behavioral Neuroscience · doi:10.1037/0735-7044.114.6.1156 · Cited by 59 · see citing works
Kalinichev, M., White, D. A., & Holtzman, S. G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1990-8 · Cited by 50 · see citing works
Current Drug Therapy Recommendations for the Treatment of Attention Deficit Hyperactivity Disorder
Cyr, M., & Brown, C. (1998) · Drugs · doi:10.2165/00003495-199856020-00005 · Cited by 47 · see citing works
Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons
Nielsen, J. A., Shannon, N., Bero, L. A., & Moore, K. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90413-2 · Cited by 45 · see citing works
Gingras, M. A., & Cools, A. R. (1996) · Psychopharmacology · doi:10.1007/bf02247337 · Cited by 45 · see citing works
Carey, R. J., & Damianopoulos, E. N. (1994) · Behavioural Brain Research · doi:10.1016/0166-4328(94)90026-4 · Cited by 42 · see citing works
Bevins, R. A. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.06.002 · Cited by 40 · see citing works
The conditioned place preference paradigm in rats: Effect of bupropion
Ortmann, R. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90033-5 · Cited by 38 · see citing works
Szumlinski, K. K., Haskew-Layton, R. E., Balogun, M. Y., Maisonneuve, I. M., & Glick, S. D. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00564-0 · Cited by 28 · see citing works
Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats
Wilkinson, J. L., Palmatier, M. I., & Bevins, R. A. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200500484642 · Cited by 20 · see citing works
Adams, J. U., Careri, J. M., Efferen, T. R., & Rotrosen, J. (2000) · Psychopharmacology · doi:10.1007/s002130000431 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Carvalho, M. M., Campos, F. L., Coimbra, B., Pêgo, J. M., Rodrigues, C., Lima, R., Rodrigues, A. J., Sousa, N., & Salgado, A. J. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-14 · Cited by 184 · see citing works
Nicotine exposure during adolescence induces a depression-like state in adulthood
Iñiguez, S. D., Warren, B. L., Parise, E. M., Alcantara, L. F., Schuh, B., Maffeo, M. L., Manojlovic, Z., & Bolaños-Guzmán, C. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.220 · Cited by 157 · see citing works
Arias, H. R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.05.015 · Cited by 77 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Neurophysiology of Nicotine Addiction
Dani, J. A., Jenson, D., & Broussard, J. I. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s1-001 · Cited by 53 · see citing works
Bupropion attenuates methamphetamine self-administration in adult male rats
Reichel, C. M., Murray, J. E., Grant, K. M., & Bevins, R. A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.09.006 · Cited by 46 · see citing works
Palmatier, M. I., Levin, M. E., Mays, K. L., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1666-5 · Cited by 40 · see citing works
Reichel, C. M., Wilkinson, J. L., & Bevins, R. A. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f14efc · Cited by 28 · see citing works
Exposure to dilute concentrations of bupropion affects zebrafish early life stages
Franco, M. B., Andrade, T. S., Sousa-Moura, D., da Silva, M. L., Ferraz, I. B. M., Camargo, N. S., Domingues, I., Oliveira, R., & Grisólia, C. K. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.01.141 · Cited by 25 · see citing works
Wilkinson, J. L., Li, C., & Bevins, R. A. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00141.x · Cited by 25 · see citing works
Charntikov, S., Pittenger, S. T., Pudiak, C., & Bevins, R. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.021 · Cited by 24 · see citing works
An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine
Wilkinson, J., Carroll, F. I., & Bevins, R. A. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102518 · Cited by 19 · see citing works
A novel approach for predicting antidepressant-induced sexual dysfunction in rats
Rizzo, S. J. S., Schechter, L. E., & Rosenzweig-Lipson, S. J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0924-7 · Cited by 20 · see citing works
Carrasco, M. C., Vidal, J., & Redolat, R. (2013) · Behavioural Processes · doi:10.1016/j.beproc.2013.05.002 · Cited by 11 · see citing works
Naglich, A. C., Brown, E. S., & Adinoff, B. H. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1545023 · Cited by 11 · see citing works
Cain, M. E., Coolon, R. A., & Gill, M. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.007 · Cited by 8 · see citing works
Effects of bupropion on the ejaculatory response of male rats
Hueletl-Soto, M. E., Carro-Juárez, M., & Rodrı́guez–Manzo, G. (2014) · International Journal of Impotence Research · doi:10.1038/ijir.2014.12 · Cited by 5 · see citing works
Moran, A. E., Huynh, Y. W., Finkner, A., Selleck, C., Thompson, A., Barrett, S. T., & Bevins, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06072-1 · Cited by 2 · see citing works
- Authors
- Wilkinson, J. L., & Bevins, R. A.
- Affiliations
- University of Nebraska–Lincoln (US)
- Corresponding author
- Bevins, Rick A.
- ORCID
- Bevins, Rick A.
- Venue
- Physiology & Behavior
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 90
- Issue
- 5
- Pages
- 790-796
- ISSN
- 0031-9384 (ISSN-L)
- OpenAlex
- W2023597280
- Cited by
- 18
- References
- 48
- Citations by year
- 2022: 1 · 2019: 2 · 2018: 1 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Physiology & Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA018114, DA018114)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- bupropion, psychostimulants, locomotor hyperactivity, novelty reactivity, environmental cues, antidepressants, smoking cessation
- MeSH terms
- Central Nervous System Stimulants, Analysis of Variance, Animals, Association Learning, Behavior, Animal, Conditioning, Classical, Dose-Response Relationship, Drug, Exploratory Behavior, Hyperkinesis, Male, Random Allocation, Bupropion, Rats, Sprague-Dawley, Antidepressive Agents, Second-Generation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review